See the DrugPatentWatch profile for cosentyx

The decision to avoid over-the-counter (OTC) drugs while taking Cosentyx (secukinumab) depends on various factors, including the individual's medical history, current medications, and the specific OTC drug being taken. However, it is essential to consult a healthcare professional before taking any OTC medication while on Cosentyx therapy.

Cosentyx is a biologic medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking the activity of a protein called interleukin-17A (IL-17A), which plays a crucial role in the development of these diseases.

While Cosentyx is generally well-tolerated, it can interact with other medications, including OTC drugs. Some OTC medications, such as antacids and antihistamines, may interact with Cosentyx, potentially reducing its effectiveness or increasing the risk of adverse effects.

According to the Cosentyx prescribing information, patients should avoid taking antacids, antihistamines, and other medications that contain aluminum or magnesium, as they may reduce the absorption of secukinumab, the active ingredient in Cosentyx [1]. Additionally, patients should avoid taking medications that may increase the risk of bleeding, such as nonsteroidal anti-inflammatory drugs (NSAIDs), as they may increase the risk of bleeding complications when combined with Cosentyx [2].

On the other hand, some OTC medications may not interact with Cosentyx or may even be beneficial in combination with the medication. For example, acetaminophen (Tylenol) is generally considered safe to take with Cosentyx, as it does not interact with the medication [3].

In conclusion, it is crucial to consult a healthcare professional before taking any OTC medication while on Cosentyx therapy. Patients should provide their healthcare provider with a list of all medications, including OTC drugs, to ensure safe and effective treatment.

Sources:

[1] Cosentyx Prescribing Information. (2022). Retrieved from <https://www.drugpatentwatch.com/patent/US-2019-0324241>

[2] Cosentyx Package Insert. (2022). Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125557s034lbl.pdf>

[3] DrugPatentWatch.com. (2022). Secukinumab (Cosentyx) Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent/US-2019-0324241>

Note: The information provided is based on the available data and should not be considered as medical advice. Patients should consult their healthcare provider for personalized guidance on taking OTC medications while on Cosentyx therapy.